Chengdu New Radiomedicine Technology Co. Ltd.

This early-stage study tested a new drug called NRT6003 in 40 adults with liver cancer that cannot be surgically removed. The main goals were to check for side effects and see if the injection shrinks tumors in the liver. Researchers also measured how long the tumors stayed contr…